Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Ehealth System Support For Symptom Management Via Cankado

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT03911219Completed

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

Showing all 1 trials

Research Network

Common Treatments

  • Ehealth System Support For Symptom Management Via Cankado1

Active Sponsors

  • Roche Pharma AG1
  • iOMEDICO AG1

Top Investigators

Related Conditions

  • Stage Iv Nonsmall Cell Lung Cancer1
  • Extensivestage Small Cell Lung Cancer1

Activity Timeline